The ReShape Duo (made by ReShape Medical, Inc.) is a gastric balloon operation, which is considered part of the bariatric surgery subset, and designed for individuals to lose weight. The ReShape Duo non-surgical weight management system is a newer FDA-approved implant with significant benefits over the traditional gastric balloon surgery. Equally distributed between the two balloons, they take up a total volume of 900 mL, filled with methylene blue-mixed saline. In a recent study, patients who had the dual balloon lost 14.3 lbs. in six months, verse 7.1 lbs without the balloon in six months.
More surprisingly, equipped with better eating and lifestyle choices, patients kept off 9.9 lbs(from the original 14.3 lbs) six months after the ReShape Duo was removed.
Benefits of Gastric Balloon Operation vs. Bariatric Surgery:
- Not permanent operation.
- Not a surgery, rather an endoscopic procedure.
- No rerouting of your digestive tract.
- No incisions or scars.
- Balloon procedure is done in just about 20 minutes, as an out-patient procedure.
- Two balloons allow for more capacity, for more potential for weight loss.
- The shape of the balloon is designed for more comfort in the stomach.
- Each balloon is independent of each other, with allows for greater security.
- Placement of the ReShape Duo is done endoscopically, with no need for surgery.
Key Surgery Takeaways:
- Average Time Inserted: 6 Months.
- Average Operation Time: 30 Minutes
Am I Candidate for ReShape Duo:
The ideal candidate for the ReShape Duo is somebody with a BMI between 30 to 40, and somebody who has tried several times to lose weight through diet and exercise. Additionally, an individual with co-morbidities, such as type 2 diabetes, hypertension, and high cholesterol are also considered proper candidates for the operation.
The area in blue is considered a good candidate for gastric balloon procedure. Contact us to inquire about your candidacy for this procedure.
ReShape Duo: Bariatric Operation in Mexico
Undergoing bariatric surgery in Mexico is a great option for those who need access to qualified bariatric professionals who can perform the procedure in a quick timeline (click here for more information on gastric balloon in Mexico). Other benefits of undergoing medical tourism in Mexico include more affordable options and a better understanding of the procedure and implant. Our surgeons have been performing intragastric balloon, as a treatment for obesity, for over 10 years. Contact our helpful team today to learn about our options in Tijuana, Mexico.
Risks of the ReShape Duo Surgery:
Common risks of the ReShape Duo Surgery include balloon deflation and intestinal obstruction. Intestinal obstruction risk is more pronounced with inside the stomach for longer than six months.
Migration of the balloon may occur and has a greater frequency in left in patients longer than 6 months. If migration of balloon occurs, it may obstruct the intestines and therefore may need surgical or endoscopic removal.
Patients will need to take a daily proton-pump inhibitor medication, for if they fail to do so, the risks include gastric ulceration or perforation.
Other Risks of ReShape Duo Include:
- Abdominal Pain
- A sore Throat
The placement of the ReShape Duo will do endoscopically, requiring sedation. Minor complications may include headaches, muscle pains, and nausea.
Risks of Sedation Include:
- Respiratory Distress
Complications and Side Effects
- Blue or green color urine
- Balloon Deflation: sudden loss of satiety that can increase hunger. This is typically a sign of the ReShape Duo balloon(s) deflating.
Contraindications: The ReShape Integrated Dual Balloon System is not recommended for patients with conditions that may increase the risk of poor results (e.g., prior gastrointestinal surgery with sequelae, prior open or laparoscopic bariatric surgery, inflammatory diseases of the GI tract, potential upper GI bleeding), who are unwilling to participate in an established medically-supervised diet and behavior modification program, who have alcohol or drug addictions, who receive daily prescribed treatment with aspirin, anti-inflammatory agents, anticoagulants or other gastric irritants, or who currently are or may be pregnant or breast-feeding. [SOURCE]